Immune pathogenesis of hepatitis B
Available information about the immune pathogenesis of HBV infection in man is very limited. However, the present availability of recombinant sources of the different HBV antigens expressed in the appropriate forms to induce activation of either HLA class I or HLA class II-restricted T cells, provides the necessary tools to investigate directly the mechanisms of liver damage, the role of the different cellular components of the immune system in HBV clearance and the specific nature of the immune defects potentially responsible for the chronic evolution of HBV infection. In addition, improved knowledge of HBV biology suggests a dynamic interpretation of the HBV-immune system interactions, based on which viral mutations as well as direct interferences of HBV with specific immune functions are believed to play a relevant role with respect to the outcome of HBV infection.
KeywordsWoodchuck Hepatitis Virus Immune Pathogenesis Eddleston ALWF Nucleocapsid Antigen Hepadnavirus Infection
Unable to display preview. Download preview PDF.
- 11. .
- 17.Mondelli M, Mieli-Vergani G, Alberti A, Vergani D, Portmann B, Eddieston ALWF, Williams R (1982) Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129: 2773–2777PubMedGoogle Scholar
- 19.Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M (1990) Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 1298–1303PubMedGoogle Scholar
- 21.Penna A, Fowler P, Bertoletti A, Guilhot S, Moss B, Margolskee RF, Cavalli A, Valli A, Fiaccadori F, Chisari FV, Ferrari C (1992) Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTL that recognize endogenously synthesized HBV envelope antigens. J Virol 66: 1193–1198PubMedGoogle Scholar
- 27.Stemler M, Weimer T, Tu SX, Wan DF, Levrero M, Jung C, Pape GR, Will H (1990) Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Hepatol 64: 2802–2809Google Scholar